← Leaderboards
Hongshuai Li
University Of Pittsburgh At Pittsburgh
$2,775,048
Attributed
$2,775,048
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $907.9K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,775,048 · 2
By mechanism
R01$2,775,048 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Francisco Jose Schopfer$8,044,712
- Alison Morris$31,399,077
- Xiao Xiao$14,631,158
- Adam J Santanasto$1,248,489
- Sruti Shiva$9,895,872
Others in their field
Other Emerging Leaders on “Muscular Dystrophies”
- Amy Brower · American College Of Medical Genetics$8,744,067
- Buel Rodgers · Aavogen, Inc.$4,266,268
- Patricio Sepulveda · Amplo Biotechnology, Inc.$3,794,083
- Courtney S Young · Myogene Bio, Llc$3,772,804
- Foteini Mourkioti · University Of Pennsylvania$3,480,431
- Melissa A.h. Witman · University Of Delaware$3,294,446
Research focus
Muscular DystrophiesPhysiologicalHomeostasisMusclePathogenesisPathologyDuchenne Muscular DystrophyFibroblast Growth Factor 21MediatingMouse ModelNovel Therapeutic InterventionOsteoporosisBone LossPathologicDisease ProgressionCellsEffective TherapyBone QualityInsightIn VivoBoneMolecularAffectRecombinant Fibroblast Growth Factor
Grant awards (7)
Role of FGF21 in DMD$557,423
R01 · FY2025 · AR · contact PI
Role of FGF21 in DMD$585,000
R01 · FY2024 · AR · contact PI
Targeting Nitrate-Nitrite-NO pathway for Ameliorating Muscle and Bone Comorbidities in Duchenne Muscular Dystrophy$322,931
R01 · FY2024 · AR · contact PI
Targeting Nitrate-Nitrite-NO pathway for Ameliorating Muscle and Bone Comorbidities in Duchenne Muscular Dystrophy$332,919
R01 · FY2023 · AR · contact PI
Targeting Nitrate-Nitrite-NO pathway for Ameliorating Muscle and Bone Comorbidities in Duchenne Muscular Dystrophy$336,258
R01 · FY2022 · AR · contact PI
Targeting Nitrate-Nitrite-NO pathway for Ameliorating Muscle and Bone Comorbidities in Duchenne Muscular Dystrophy$329,703
R01 · FY2021 · AR · contact PI
Targeting Nitrate-Nitrite-NO pathway for Ameliorating Muscle and Bone Comorbidities in Duchenne Muscular Dystrophy$310,814
R01 · FY2020 · AR · contact PI